TCON
TRACON Pharmaceuticals Inc

8,517
Loading...
Loading...
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for TRACON Pharmaceuticals Inc?
What is the 52-week low for TRACON Pharmaceuticals Inc?
What is TRACON Pharmaceuticals Inc stock price today?
What was TRACON Pharmaceuticals Inc stock price yesterday?
What is the 50-day moving average of TRACON Pharmaceuticals Inc?

Latest TCON News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.